New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2014
09:09 EDTCURNeuralstem raises $19.65M in a registered direct offering
Neuralstem announced that it has entered into agreements with leading institutional investors for a registered direct placement of 6,752,744 shares of common stock at a price of $2.91 per share, resulting in aggregate gross proceeds of approximately $19.65 million. T.R. Winston & Company, LLC acted as the exclusive placement agent for the offering.
News For CUR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2015
08:09 EDTCURNeuralstem reports good tolerance in NSI-566 trial in ALS
Neuralstem announced that nine-month Phase II and combined Phase I and Phase II data on the NSI-566 trial in amyotrophic lateral sclerosis, or ALS, was presented at the American Neurological Association Annual Meeting. The data showed that the intraspinal transplantation of the cells was safe and well-tolerated throughout the escalating doses, reaching a maximum tolerated dose of 16 million cells via 20 bilateral injections. There appeared to be no acceleration in disease progression due to the therapeutic intervention. Researchers calculated a 95% confidence limit around the slopes of decline of ALSFRSr scores, forced vital capacity and grip strength of the ProAct historical database subjects, and evaluated if trial subjects fell within or outside those limits.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use